Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2000

View Archived Issues

Licensing opportunity from NIH: modified HCV peptide vaccine

Genentech and Aradigm commence phase II study of CF therapy

FDA accepts InKine's Diacol NDA for filing

The Medicines Company acquires bacterial vaginosis treatment from GyneLogix

Medinox's NO neutralizer blocks sepsis in rat model

Antisense oligonucleotides designed at Isis for modulating PKC expression

DuPont scientists prepare new antiplatelet fibrinogen antagonists

Ontogen achieves milestone in PTPase collaboration with Novo Nordisk

Lilly designs new series for activating the 5-ht1f receptor

Anticancer and antimetastatic integrin inhibitors in the pipeline at BioChem Pharma

Antimalarial benflumetol derivatives with improved activity disclosed by Novartis

4-Arylpiperidines as 5-HT reuptake inhibitors

Novel, highly water soluble salt of sildenafil suitable for intranasal administration

Revised labeling for Propulsid prompted by continuing reports of cardiac adverse events

Angstrom's A6 receives U.S. patent protection; company preparing to begin phase I trials

Metabolex acquires Shaman's antidiabetic drug development program

Advanced cancer stabilized by copper-lowering drug in U-M study

Biomira initiates next stage of phase II testing of BLP25/liposomal IL-2

U.S. patent issues for Ribozyme's hepatitis B virus ribozyme

PADRE technology shows promise as universal vaccine immune stimulant

Overcoming antibiotic resistance: unusually high bactericidal activity of nisin explained

Synaptic and Kissei enter genomics research collaboration

Phase III results disappointing for marimastat in pancreatic cancer

Scios discusses plans for p38 kinase inhibitors

IL-9 expression increased in asthma

EPISTENT diabetic subgroup results: abciximab + stenting associated with better outcome

Amgen files for regulatory approval of NESP and Kineret during 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...